AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pluri Inc. Board/Management Information 2021

Jul 19, 2021

6990_rns_2021-07-19_f252f61e-5089-47fb-9313-508a6c99c07f.htm

Board/Management Information

Opens in your device viewer

_________ false


��	2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	8544
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	19/07/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-118812	Time of broadcast: 13:51 13:51

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on_________

Board_nomination_July2021_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 15/06/2021
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected] Company site: www.pluristem.com

Previous names of reporting entity:

Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2